Schedule 13G ownership disclosure

DRUGS MADE IN AMER ACQUTN CO

Common · CUSIP: G2847J104

Event date: 2025-03-31

Filing-level shares
2,324,034.00
Percent of class
6.93%
  • KARPUS MANAGEMENT, INC.

    Shares: 2,324,034.00 · Class: 6.93%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001072613-25-000381
Form type
SCHEDULE 13G
Filer
Drugs Made In America Acquisition Corp.
CIK
CIK 2028614
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub